Full-Time

Key Account Manager

Transplant

Posted on 3/13/2025

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$154.4k - $212.3k/yr

+ Short-term Incentives + Long-term Incentives

Senior

Los Angeles, CA, USA

Must live within 50 miles of the center of the territory – Los Angeles North

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Data Analysis
Requirements
  • Bachelor’s degree – BA/BS
  • 5 years direct selling experience to healthcare professionals in the pharmaceutical, biotech, device, specialty or healthcare industry required that included the following:
  • Develop and execute business plans aligned with corporate objectives
  • Launch business development initiatives and strategy for execution
  • Advanced business skills in negotiation, strategy, presentation, analytics and teamwork
  • Strong collaboration working within teams
  • Demonstrated business and strategic planning skills to identify unique selling opportunities and adaptability to changing market conditions
  • Understanding of managed care landscape and how it influences/impacts business
  • Strong verbal, influencing, presentation and written communication skills, Strong collaboration skills and success working in teams
  • Must Reside within assigned geography
  • You are required to obtain and maintain Hospital Credentialing to gain access and work with HCPs in the hospital environment. Hospital credentialing requirements may include, but are not limited to, background checks, drug screens, proof of immunization/vaccination for various diseases and specific training and other credentialing requirements based on customer requirements.
Responsibilities
  • Achieve or exceed sales targets and Management by Objective (MBO) goals.
  • Develop and execute strategic and tactical account planning, such as uncovering needs, stakeholder / influence mapping, identifying / prioritizing business goals, helping define value propositions, delivering value propositions developed in collaboration with marketing and managed market teams, developing tactical plans, etc.
  • Develop a comprehensive, territory-specific business plan which includes strategies and tactics aimed at achieving corporate objectives.
  • Gain access for specialty products in accounts, in terms of protocol access (inclusion of specialty products in clinical/prescriber protocols and clinical pathways), and formulary access, if applicable.
  • Conduct account management at all transplant centers within the assigned territory, foster confidence in Takeda’s holistic approach to engagement, and assist with on-going service and support as needed.
  • Develop relationships with Executive Level, Operations, Financial, and Pharmacy-based personnel within each of the transplant centers in their territory. Calls on key stakeholders to position Takeda’s products and to ensure effective supply, and support of Takeda’s product portfolio.
  • Develop relationships with Thought Leaders and leverage relationships with clinical experts to apply at account levels to educate and inform therapeutic processes and protocols at an institution level.
Desired Qualifications
  • Experience within transplant and/or rare disease is highly preferred
  • Account-based sales (e.g. hospital, health system, infusion centers and large group practice) experience or experience within rare disease developing centers of excellence or working with comprehensive care teams in a holistic diagnosis and support model
  • Experience with buy & bill product selling/account management
  • Understand payer access and reimbursement at assigned regional, state, and local levels
  • Advanced business or scientific degree (MBA, MS, PharmD, etc.)
  • Experience managing and communicating complex reimbursement issues
  • Experience with complex selling situations
  • Pharmaceutical product launch experience
  • Experience calling on specialists involved in transplant: Hematologist Oncologist, Infectious Disease, Nephrologist, Pulmonologist, Hepatologist, Cardiologist, etc.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

INACTIVE